Rapid progression of anemia related to tumor-lysis syndrome associated with bortezomib treatment in myeloma patients.
Rapid progression of anemia related to tumor-lysis syndrome associated with bortezomib treatment in myeloma patients. Jpn J Clin Oncol. 2014 May; 44(5):435-41.